| Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. | |
| | |
MedLine Citation:
|
PMID: 20876673 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVES: Iron (Fe) overload may complicate parenteral Fe therapy used to enhance the efficacy of erythropoietic-stimulating agents in the treatment of anemia of chronic kidney disease. However, serum Fe markers are influenced by inflammation or malignancy and may not accurately reflect the amount of body Fe. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied the relationship between parenteral Fe therapy, conventional serum Fe markers, and liver iron concentration (LIC) measured using magnetic resonance R2 relaxometry (FerriScan) in 25 Fe-deficient predialysis chronic kidney disease patients before and 2 and 12 weeks after single high-dose intravenous Fe and in 15 chronic hemodialysis patients with elevated serum ferritin (>500 μg/L). RESULTS: In predialysis patients, there was strong dose dependency between the administered Fe dose and changes in LIC at weeks 2 and 12; however, no dose dependency between Fe dose and changes in ferritin or transferrin saturation (TSAT) were observed. In hemodialysis patients, LIC correlated with the cumulative Fe dose and duration of dialysis but not with current ferritin or TSAT. The cumulative Fe dose remained a significant independent predictor of LIC in a multiple regression model. Two dialysis patients who received >6 g parenteral Fe had substantially elevated LIC >130 μmol/g, which is associated with hemochromatosis. CONCLUSIONS: In Fe-deficient predialysis patients, intravenous Fe therapy is associated with increases in LIC unrelated to changes in conventional Fe markers. In hemodialysis patients, TSAT and ferritin are poor indicators of body Fe load, and some patients have LICs similar to those found in hemochromatosis. |
| | |
Authors:
|
Paolo Ferrari; Hemant Kulkarni; Shyam Dheda; Susanne Betti; Colin Harrison; Timothy G St Pierre; John K Olynyk |
Related Documents
:
|
7073223 - Studies on the anaemia of asian patients with chronic renal failure undergoing regular ... 15024453 - Audit of investigations in patients with iron deficiency anaemia. 12827003 - Gastric electric activity assessed by electrogastrography and gastric emptying scintigr... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-09-28 |
Journal Detail:
|
Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 6 ISSN: 1555-905X ISO Abbreviation: Clin J Am Soc Nephrol Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-20 Completed Date: 2011-05-18 Revised Date: 2012-01-02 |
Medline Journal Info:
|
Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 77-83 Citation Subset: IM |
Affiliation:
|
Department of Nephrology, Fremantle Hospital, Alma Street, Perth, Western Australia 6160, Australia. paolo.ferrari@health.wa.gov.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Chronic Disease Cross-Sectional Studies Female Ferritins / blood* Hemoglobins / analysis Humans Iron / deficiency, therapeutic use* Kidney Diseases / blood* Liver / metabolism Male Middle Aged Prospective Studies Renal Dialysis Transferrin / analysis* |
| Chemical | |
Reg. No./Substance:
|
0/Hemoglobins; 0/Transferrin; 7439-89-6/Iron; 9007-73-2/Ferritins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Value of the new bone classification system for pediatric patients with chronic kidney disease.
Next Document: Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort.